Biogenity ApS: Financial statements 2025
CVR: 39606925
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
Biogenity ApS (CVR 39606925) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,387,873 and a net result of DKK -453,753 compared with DKK -342,877 the year before. That is a decrease of 26.9% compared with the year before. Equity in the 2025 report amounted to DKK -189,867. The company had 4 employees in the financial year.
- Gross Profit
- DKK 1,387,873
- Profit/Loss
- DKK -453,753
- Equity
- DKK -189,867
- Total Assets
- DKK 1,761,586
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.4 mio. | -454 t. | -190 t. | 4 |
| 2024 | - | 1.9 mio. | -343 t. | 264 t. | 6 |
| 2023 | - | 2.4 mio. | 449 t. | 607 t. | 5 |
| 2022 | - | 1.3 mio. | -108 t. | 143 t. | 5 |
| 2021 | - | 97 t. | 117 t. | 250 t. | 3 |
Official annual report
How creditworthy is Biogenity ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Biogenity ApS
Biogenity ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kenneth Kastaniegaard and Louis Loeb. The board consists of Louis Loeb (chair) and Kenneth Kastaniegaard. The company is owned by L.Loeb Holding ApS and Kastaniegaard Holding ApS. According to the 2025 annual report, the company had an average of 4 employees. In 2025, the company reported a gross profit of DKK 1,387,873 and a net result of DKK -453,753 compared with DKK -342,877 the year before. Equity in the 2025 report amounted to DKK -189,867.